Maria Kotlyar, Head of Strategic Planning and Financial Accounts Department, Farmak, spoke on the international conference «Financial Risk Management in Corporations» held on 17 April 2014 in Radisson Blu hotel (Kyiv). The conference was arranged by Worldwide Expert, British company.
Maria Kotlyar told the participants about the approaches to currency risk hedging, analyzed corporate risks in servicing currency credit portfolio, and presented a model defining basic limits and parameters with respect to instruments used for currency risk management (based on the example of Farmak).
The development of a financial risk management system, increase in company’s shareholder value, and improvement of liquidity through risk management were the main issues considered during the conference. A special emphasis was on the legal and tax aspects of currency legislation, transfer pricing, dividends, derivatives and other financial instruments. The participants had an opportunity to learn the best practices on Ukrainian business arena.
Maria Kotlyar, Head of Strategic Planning and Financial Accounts Department, Farmak, says, “Considering the recent trends in the economic environment of Ukraine, devaluation of the national currency and unpredictable fluctuations in exchange rates, this conference is extremely important for financial experts from different business areas”.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...